Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Terns Pharmaceuticals Inc 1065 EAST HILLSDALE BLVD. SUITE 100 FOSTER CITY CA 94404 USA

www.ternspharma.com Employees: 59 P: 650-525-5535 F: 650-275-4254

Sector:

Medical

Description:

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 3,302,333
Enterprise Value, $K 3,140,893
Shares Outstanding, K 90,080
Float, K 88,729
% Float 98.50%
Short Interest, K 15,452
Short Float 17.15%
Days to Cover 6.07
Short Volume Ratio 0.55
% of Insider Shareholders 1.50%
% of Institutional Shareholders 98.26%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -88,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,640 K
EBIT, $ -108,480 K
EBITDA, $ -107,580 K

Growth:

1-Year Return 670.24%
3-Year Return 363.46%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 11/10/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -1.03
EPS Growth vs. Prev Qtr -3.85%
EPS Growth vs. Prev Year 3.57%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TERN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.95%
Return-on-Assets % -28.50%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 11.27
Book Value/Share 3.25
Interest Coverage -1.79
60-Month Beta -0.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar